advisorsecurities master

CSTLCastle Biosciences, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
13856
Ticker
CSTL
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2019-07-25
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CSTL

Detail

Enriched 2026-08-14 20:47

Market cap
$960,171,005.01
Shares outstanding (class)
30,549,507
Shares outstanding (weighted)
30,549,507
SIC
8071 SERVICES-MEDICAL LABORATORIES
Employees
1,002
Location
FRIENDSWOOD, TX
Description

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data